PAR2 knock-out C57Bl6 mice as a model for evaluating metastases of cancer cells: Pilot in vivo study of the metastatic potential of B16 melanoma in knock-out (PAR2-/-) animals

Folia Biologica (Czech Republic)

Volumn 58, Issue 2, 2012, Pages 81-86

  Matej, R ^a,b   Zadinova M ^b   Pouckova P ^b   Kukal, J ^c   Olejar T ^a,b  

^a FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CZECH TECHNICAL UNIVERSITY IN PRAGUE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; GENE INACTIVATION; HISTOPATHOLOGY; IN VIVO STUDY; LUNG METASTASIS; MELANOMA B16; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PILOT STUDY; TUMOR RECURRENCE; TUMOR VOLUME; ANIMAL; C57BL MOUSE; CANCER INVASION; CANCER TRANSPLANTATION; CELL MOTION; EXPERIMENTAL MELANOMA; GENETICS; MALE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PIGMENTATION; SKIN TUMOR; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PIGMENTATION; PILOT PROJECTS; RECEPTOR, PAR-2; SKIN NEOPLASMS;

EID: 84866250625     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Adams, M. N., Ramachandran, R., Yau, M. K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., Hooper, J. D. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacol. Ther. 130, 248-282.
2. Al-Ani, B., Hewett, P. W., Cudmore, M. J., Fujisawa, T., Saifeddine, M., Williams, H., Ramma, W., Sissaoui, S., Jayaraman, P. S., Ohba, M., Ahmad, S., Hollenberg, M. D., Ahmed, A. (2010) Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells. Hypertension 55, 689-697.
3. Bhatt, D. K., Ploug, K. B., Ramachandran, R., Olesen, J., Gupta, S. (2010) Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery. Headache 50, 1017-1030.
4. Déry, O., Thoma, M. S., Wong, H., Grady, E. F., Bunnett, N. W. (1999) Trafficking of proteinase-activated receptor-2 and β-arrestin-1 tagged with green fluorescent protein. β-Arrestin-dependent endocytosis of a proteinase receptor. J. Biol. Chem. 274, 18524-18535.
5. Elste, A. P., Petersen, I. (2010) Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer. J. Mol. Histol. 41, 89-99.
6. Fields, R. C., Schoenecker, J. G., Hart, J. P., Hoffman, M. R., Pizzo, S. V., Lawson, J. H. (2003) Protease-activated receptor-2 signaling triggers dendritic cell development. Am. J. Pathol. 162, 1817-1822. (Pubitemid 36613040)
7. Hansen, K. K., Oikonomopoulou, K., Baruch, A., Ramachandran, R., Beck, P., Diamandis, E. P., Hollenberg, M. D. (2008) Proteinases as hormones: targets and mechanisms for proteolytic signaling. Biol. Chem. 389, 971-982.
8. Jiang, B., Grage-Griebenow, E., Csernok, E., Butherus, K., Ehlers, S., Gross, W. L., Holle, J. U. (2010) The role of proteinase 3 (PR3) and the protease-activated receptor-2 (PAR-2) pathway in dendritic cell (DC) maturation of human-DC-like monocytes and murine DC. Clin. Exp. Rheumatol. 28 (Suppl 57), 56-61.
9. Kawabata, A., Kuroda, R., Minami, T., Kataoka, K., Taneda, M. (1998) Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br. J. Pharmacol. 125, 419-422. (Pubitemid 28451476)
10. Mannowetz, N., Würdinger, R., Zippel, A., Aumüller, G., Wennemuth, G. (2010) Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia. Prostate 70, 1350-1358.
11. Matej, R., Mandáková, P., Netíková, I., Poucková, P., Olejár, T. (2007) Proteinase-activated receptor-2 expression in breast cancer and the role of trypsin on growth and metabolism of breast cancer cell line MDA MB-231. Physiol. Res. 56, 475-484.
12. McEachron, T. A., Pawlinski, R., Richards, K. L., Church, F. C., Mackman, N. (2010) Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis. Blood 116, 5037-5044.
13. Nakanuma, S., Tajima, H., Okamoto, K., Hayashi, H., Nakagawara, H., Onishi, I., Takamura, H., Kitagawa, H., Fushida, S., Tani, T., Fujimura, T., Kayahara, M., Ohta, T., Wakayama, T., Iseki, S., Harada, S. (2010) Tumour-derived trypsin enhances proliferation of intrahepatic cholangiocarcinoma cells by activating protease-activated receptor-2. Int. J. Oncol. 36, 793-800.
14. Ramelli, G., Fuertes, S., Narayan, S., Busso, N., Acha-Orbea, H., So, A. (2010) Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo. Immunology 129, 20-27.
15. Soh, U. J., Dores, M. R., Chen, B., Trejo, J. (2010) Signal transduction by protease-activated receptors. Br. J. Pharmacol. 160, 191-203.
16. Suen, J.Y., Gardiner, B., Grimmond, S., Fairlie, D. P. (2010) Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells. PLoS One 5, e13809
17. Wald, M., Olejár, T., Sebková, V., Zadinová, M., Boubelík, M., Poucková, P. (2001) Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16. Cancer Chemother. Pharmacol. 47 (Suppl), S16-22.
18. Wang, X., Liu, H. T., Li, S., Li, K., Lin, N., Fan, Q. X., Zheng, Y. L. (2010) Prognostic value of protease-activated receptor 2 expression in oesophageal squamous cell carcinoma. J. Int. Med. Res. 38, 1381-1388.
19. Yang, X. P., Li, Y., Wang, Y., Wang, Y., Wang, P. (2010) β-Tryptase up-regulates vascular endothelial growth factor expression via proteinase-activated receptor-2 and mitogen-activated protein kinase pathways in bone marrow stromal cells in acute myeloid leukemia. Leuk. Lymphoma 51, 1550-1558.
20. Yoshida, N., Takagi, T., Isozaki, Y., Suzuki, T., Ichikawa, H., Yoshikawa, T. (2011) Proinflammatory role of proteaseactivated receptor-2 in intestinal ischemia/reperfusion injury in rats. Mol. Med. Report. 4, 81-86.
21. Zhang, X., Wang, W., True, L. D., Vessella, R. L., Takayama, T. K. (2009) Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis. Prostate 69, 727-736.